185 related articles for article (PubMed ID: 15251267)
1. Sex differences and repeated intravenous nicotine: behavioral sensitization and dopamine receptors.
Harrod SB; Mactutus CF; Bennett K; Hasselrot U; Wu G; Welch M; Booze RM
Pharmacol Biochem Behav; 2004 Jul; 78(3):581-92. PubMed ID: 15251267
[TBL] [Abstract][Full Text] [Related]
2. Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats.
Le Foll B; Diaz J; Sokoloff P
Synapse; 2003 Mar; 47(3):176-83. PubMed ID: 12494400
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in nicotine sensitization and conditioned hyperactivity in adolescent rats neonatally treated with quinpirole: role of D2 and D3 receptor subtypes.
Sheppard B; Lehmann J; Cope ZA; Brown RW
Behav Neurosci; 2009 Dec; 123(6):1296-308. PubMed ID: 20001113
[TBL] [Abstract][Full Text] [Related]
4. Repeated intravenous cocaine administration: locomotor activity and dopamine D2/D3 receptors.
Wallace DR; Mactutus CF; Booze RM
Synapse; 1996 Jul; 23(3):152-63. PubMed ID: 8807743
[TBL] [Abstract][Full Text] [Related]
5. Testing environment shape differentially modulates baseline and nicotine-induced changes in behavior: Sex differences, hypoactivity, and behavioral sensitization.
Illenberger JM; Mactutus CF; Booze RM; Harrod SB
Pharmacol Biochem Behav; 2018 Feb; 165():14-24. PubMed ID: 29273458
[TBL] [Abstract][Full Text] [Related]
6. Enhanced apomorphine sensitivity and increased binding of dopamine D2 receptors in nucleus accumbens in prepubertal rats after neonatal blockade of the dopamine D3 receptors by (+)-S14297.
Flores-Tochihuitl J; Vargas G; Morales-Medina JC; Rivera G; De La Cruz F; Zamudio S; Flores G
Synapse; 2008 Jan; 62(1):40-9. PubMed ID: 17957737
[TBL] [Abstract][Full Text] [Related]
7. Dopamine D1 and D2 receptor-mediated acute and long-lasting behavioral effects of glial cell line-derived neurotrophic factor administered into the striatum.
Kobayashi S; Ogren SO; Hoffer BJ; Olson L
Exp Neurol; 1998 Dec; 154(2):302-14. PubMed ID: 9878169
[TBL] [Abstract][Full Text] [Related]
8. Acute and repeated intravenous cocaine-induced locomotor activity is altered as a function of sex and gonadectomy.
Harrod SB; Booze RM; Welch M; Browning CE; Mactutus CF
Pharmacol Biochem Behav; 2005 Sep; 82(1):170-81. PubMed ID: 16139878
[TBL] [Abstract][Full Text] [Related]
9. Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice.
Risbrough VB; Masten VL; Caldwell S; Paulus MP; Low MJ; Geyer MA
Neuropsychopharmacology; 2006 Nov; 31(11):2349-58. PubMed ID: 16855533
[TBL] [Abstract][Full Text] [Related]
10. Behavioral sensitization following repeated intravenous nicotine administration: gender differences and gonadal hormones.
Booze RM; Welch MA; Wood ML; Billings KA; Apple SR; Mactutus CF
Pharmacol Biochem Behav; 1999 Dec; 64(4):827-39. PubMed ID: 10593207
[TBL] [Abstract][Full Text] [Related]
11. Differential propensity to ethanol sensitization is not associated with altered binding to D1 receptors or dopamine transporters in mouse brain.
Quadros IM; Nobrega JN; Hipólide DC; de Lucca EM; Souza-Formigoni ML
Addict Biol; 2002 Jul; 7(3):291-9. PubMed ID: 12126488
[TBL] [Abstract][Full Text] [Related]
12. Nicotine sensitization in adult male and female rats quinpirole-primed as neonates.
Perna MK; Cope ZA; Maple AM; Longacre ID; Correll JA; Brown RW
Psychopharmacology (Berl); 2008 Jul; 199(1):67-75. PubMed ID: 18548235
[TBL] [Abstract][Full Text] [Related]
13. Cocaine differentially alters behavior and neurochemistry in periadolescent versus adult rats.
Collins SL; Izenwasser S
Brain Res Dev Brain Res; 2002 Sep; 138(1):27-34. PubMed ID: 12234655
[TBL] [Abstract][Full Text] [Related]
14. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
[TBL] [Abstract][Full Text] [Related]
15. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
Neal-Beliveau BS; Joyce JN
Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
[TBL] [Abstract][Full Text] [Related]
16. The effect of nicotine induced behavioral sensitization on dopamine D1 receptor pharmacology: An in vivo and ex vivo study in the rat.
Goutier W; O'Connor JJ; Lowry JP; McCreary AC
Eur Neuropsychopharmacol; 2015 Jun; 25(6):933-43. PubMed ID: 25795518
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D1/5 and D2/3 agonists differentially attenuate somatic signs of nicotine withdrawal in rats.
Ohmura Y; Jutkiewicz EM; Zhang A; Domino EF
Pharmacol Biochem Behav; 2011 Oct; 99(4):552-6. PubMed ID: 21624384
[TBL] [Abstract][Full Text] [Related]
18. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
19. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
Hu XT; White FJ
Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
[TBL] [Abstract][Full Text] [Related]
20. Developmental alterations in locomotor and anxiety-like behavior as a function of D1 and D2 mRNA expression.
Falco AM; McDonald CG; Bachus SE; Smith RF
Behav Brain Res; 2014 Mar; 260():25-33. PubMed ID: 24239691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
